Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Albert C. Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Annals of Neurology (2019) Vol. 87, Iss. 2, pp. 206-216
Closed Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Amyotrophic lateral sclerosis
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 562
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Jonathan Mill, Merit Cudkowicz, Angela Genge, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 12, pp. 1099-1110
Open Access | Times Cited: 527
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Federico Verde, Markus Otto, Vincenzo Silani
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 106
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 69
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 59
European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)
Philip Van Damme, Ammar Al‐Chalabi, Peter M. Andersen, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 6
Open Access | Times Cited: 40
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tesfaye Wolde Tefera, Frederik J. Steyn, Shyuan T. Ngo, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 86
The amyotrophic lateral sclerosis exposome: recent advances and future directions
Stephen A. Goutman, Masha G. Savelieff, Dae-Gyu Jang, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 617-634
Open Access | Times Cited: 42
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
Johannes Dorst, Patrick Weydt, Dávid Brenner, et al.
EBioMedicine (2023) Vol. 90, pp. 104521-104521
Open Access | Times Cited: 27
Opinion: more mouse models and more translation needed for ALS
Elizabeth Fisher, Linda Greensmith, Andrea Malaspina, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Update on recent advances in amyotrophic lateral sclerosis
Nilo Riva, Teuta Domi, Laura Pozzi, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 4693-4723
Open Access | Times Cited: 12
Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis
Teresa Cunha‐Oliveira, Liliana Montezinho, Rui F. Simões, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 248-248
Open Access | Times Cited: 11
Unraveling the Heterogeneity of ALS—A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials
Laura Tzeplaeff, Alexandra V. Jürs, Camilla Wohnrade, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 452-452
Open Access | Times Cited: 10
A neuroprotective role of polyunsaturated fatty acids in C9orf72-ALS/FTD
Sandeep Kumar Dubey, Hugo J. Bellen
Nature Neuroscience (2025)
Closed Access | Times Cited: 1
Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study
Mark R. Janse van Mantgem, Ruben P. A. van Eijk, Hannelore K. van der Burgh, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 8, pp. 867-875
Closed Access | Times Cited: 68
Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?
Silvia Scaricamazza, I. Salvatori, Alberto Ferri, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 525-525
Open Access | Times Cited: 54
Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases
Ching‐Pang Chang, Kuo-Chen Wu, Chien‐Yu Lin, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 50
Long-term survival analysis of masitinib in amyotrophic lateral sclerosis
Jesús S. Mora, Walter G. Bradley, Delia Chaverri, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 49
Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis
Benjamin Rix Brooks, James Berry, Malgorzata Ciepielewska, et al.
EClinicalMedicine (2022) Vol. 52, pp. 101590-101590
Open Access | Times Cited: 36
Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine
Ira Agrawal, Yong Shan Lim, Shi‐Yan Ng, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 33
Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models
Katarina Maksimovic, Mohieldin Youssef, Justin You, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 863-863
Open Access | Times Cited: 22
Diabetes: a tipping point in neurodegenerative diseases
José A. Santiago, M. Ganesh Karthikeyan, Madison Lackey, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1029-1044
Open Access | Times Cited: 21
Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry
Sebastian Michels, Deborah Kurz, Angela Rosenbohm, et al.
Journal of Neurology (2023) Vol. 270, Iss. 6, pp. 3082-3090
Open Access | Times Cited: 19
Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
Francesco Gentile, Pietro Emiliano Doneddu, Nilo Riva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7471-7471
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top